In addition, increased FGF23 production in CKD (due to the impact of secondary hyperparathyroidism, treatment with active vitamin D metabolites, etc.)may contribute to the increased FGF23 plasma levels. This evidence concerns the gene FGF23 and chronic kidney disease.